We provide tailored strategies, practical insights, and hands-on support to empower data-driven decisions and phase-appropriate risk mitigation so you can accelerate and move confidently from discovery to development.

With decades of combined experience of biotherapeutic drug discovery experience at large pharma, biotech and start-ups, we can help you develop your target product profile, select the proper modality to fit the biology, and develop your discovery campaign and screening strategy. 

We have a proven track record of adeptly leading/overseeing discovery program teams, and have a deep understanding of the biotherapeutics landscape. Specializing in strategy and execution, we can help operationalize every step of the way – from reagent generation, early research and screening, hit-to-lead, lead optimization, and selecting development candidates for IND-enabling activities and beyond.

With our vast expertise in CRO management to enable antibody discovery, engineering and optimization, we'll help you navigate the nuanced complexity of drug discovery utilizing CROs. Having 20+ years of immunology research experience, we can also guide you through cell-based assay development to demonstrate efficacy and MOA, in vivo POC studies, and clinical indication selection.

Our expertise can also help you coordinate your IND-enabling activities - CMC, PK/PD, toxicology/safety studies, ADA/nAb/anti-Id assays & reagents - as well as translational strategy and biomarker readouts.

We'll deliver the results you need to manage key stakeholders, such as leadership teams, executive officers, board of director members, investors and partners, and enable you to deliver novel drugs to patients in need.

LEARN MORE ABOUT OUR SERVICES AND WHAT WE CAN DO FOR YOU

BACK TO WHO WE ARE